| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC5051 | |||||||||||||||||||||||
| Submitter : | Dr. Brian Donnelly | Date & Time: | 12/28/2006 09:12:02 | |||||||||||||||||||||
| Organization : | Pediatric Alliance | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| As I read report after report in the medical literature about the amazing advances using adult stem cells (and umbilical cord blood stem cells), I find it difficult to understand why the interest in embryonic stem cells persists. Using embryonic stem cells is of theoretical interest, but does not offer anything like the practical advantages that other stem cells offer us. Also, since the embryonic cells are created just to be destroyed, it does not make ethical sense to persist in "strip mining" these cells. When it comes to exploring the frontier that is stem cell research, it is best to utilize adult stem cells and unbilical cord blood.
Thank you for considering these comments. | ||||||||||||||||||||||||